Cargando…
Patient and Physician Perspectives on Systemic Sclerosis–Associated Interstitial Lung Disease
Systemic sclerosis–associated interstitial lung disease is challenging to diagnose and treat. Patients and physicians can perceive the disease differently and have different views on its management. Communication issues between them can lead to suboptimal disease management. Despite a clear need for...
Autores principales: | Cheema, Tariq J, Young, Meilin, Rabold, Erica, Barbieri, Ashley N, Baldwin, Nancy, Steen, Virginia D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081464/ https://www.ncbi.nlm.nih.gov/pubmed/32214863 http://dx.doi.org/10.1177/1179548420913281 |
Ejemplares similares
-
Interstitial Lung Disease in Systemic Sclerosis: Focus on Early Detection and Intervention
por: Fischer, Aryeh, et al.
Publicado: (2019) -
Perspectives on interstitial photodynamic therapy for malignant tumors
por: Komolibus, Katarzyna, et al.
Publicado: (2021) -
The role of precision medicine in interstitial lung disease
por: Maher, Toby M., et al.
Publicado: (2022) -
Unmet Needs for Palliation in Fibrotic Interstitial Lung Disease
por: Singhania, Sumeet Vimal Kishore, et al.
Publicado: (2018) -
Etiologic Classification of Diffuse Parenchymal (Interstitial) Lung Diseases
por: Griese, Matthias
Publicado: (2022)